Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies

Lorena Goldring; Beena Kumar; T. Eng Gan; Michael Sze Yuan Low

doi:10.1016/j.pathol.2017.03.009

Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies

Lorena Goldring, Beena Kumar, T. Eng Gan, Michael Sze Yuan Low

Immunology Alfred Hospital

Research output: Contribution to journal › Letter › Other › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	555-557
Number of pages	3
Journal	Pathology
Volume	49
Issue number	5
DOIs	https://doi.org/10.1016/j.pathol.2017.03.009
Publication status	Published - 1 Aug 2017

Access to Document

10.1016/j.pathol.2017.03.009

Cite this

@article{355229d88757464d83c47ae4668fc70a,

title = "Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies",

author = "Lorena Goldring and Beena Kumar and Gan, \{T. Eng\} and Low, \{Michael Sze Yuan\}",

year = "2017",

month = aug,

day = "1",

doi = "10.1016/j.pathol.2017.03.009",

language = "English",

volume = "49",

pages = "555--557",

journal = "Pathology",

issn = "0031-3025",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Idelalisib induced CMV gastrointestinal disease

T2 - the need for vigilance with novel therapies

AU - Goldring, Lorena

AU - Kumar, Beena

AU - Gan, T. Eng

AU - Low, Michael Sze Yuan

PY - 2017/8/1

Y1 - 2017/8/1

UR - https://www.scopus.com/pages/publications/85021723662

U2 - 10.1016/j.pathol.2017.03.009

DO - 10.1016/j.pathol.2017.03.009

M3 - Letter

C2 - 28693750

AN - SCOPUS:85021723662

SN - 0031-3025

VL - 49

SP - 555

EP - 557

JO - Pathology

JF - Pathology

IS - 5

ER -

Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies

Access to Document

Other files and links

Cite this